...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? the LInk?ping Study on Thrombosis (LIST) - A 7-year follow-up
【24h】

Is thrombin generation at the time of an acute thromboembolic episode a predictor of recurrence? the LInk?ping Study on Thrombosis (LIST) - A 7-year follow-up

机译:急性血栓栓塞发作时凝血酶的产生是否可预测复发?血栓形成性结局研究(LIST)-长达7年的随访

获取原文
获取原文并翻译 | 示例

摘要

Introduction Venous thromboembolism (VTE) is considered a chronic disease, since a high percentage of patients experience recurrences. Oral anticoagulants are effective in preventing recurrences at a price of potential bleeding complications, which underlines the importance of finding reliable markers for estimating the individual recurrence risk. In this report we evaluate thrombin generation markers at the time of an acute VTE as predictive markers for recurrence risk. Gender, presence of factor V Leiden and acquired provocative factors were taken into consideration. Additionally, we study the correlation between thrombin generation at the time of an acute VTE and thrombin generation measured four to eight weeks after discontinuation of anticoagulants. Materials and Methods The main cohort consisted of 115 patients with a confirmed thromboembolic event at inclusion. The follow-up period was seven years. Results Patients with an initial unprovoked VTE and at least one recurrence had significantly prolonged thrombin generation, whereas those without recurrences had higher maximum and total thrombin concentration. In contrast, when thrombin generation was measured one to two months after discontinuation of anticoagulant treatment, it was shown that the patients who experienced recurrences had higher maximum thrombin concentration. Conclusions Our study shows that thrombin generation profiles at the time of a VTE correlate to the clinical course after the acute episode. The great over-lap in thrombin generation between patients with and without recurrences though, makes the use of thrombin generation profiles for advice on length of oral anticoagulation for an individual patient doubtful at the present stage of knowledge. ? 2012 Elsevier Ltd. All rights reserved.
机译:简介静脉血栓栓塞症(VTE)被认为是一种慢性疾病,因为高比例的患者会复发。口服抗凝剂以预防潜在的出血并发症为代价有效地预防了复发,这凸显了寻找可靠的标记物来评估个体复发风险的重要性。在本报告中,我们评估急性VTE时的凝血酶生成标志物作为复发风险的预测标志物。性别,因素V Leiden的存在和获得性挑衅因素都被考虑在内。此外,我们研究了急性VTE时凝血酶的产生与抗凝剂停用后四到八周测量的凝血酶产生之间的相关性。材料和方法主要队列包括115例确诊为血栓栓塞事件的患者。随访期为七年。结果最初无缘无故的VTE且至少复发一次的患者凝血酶产生时间显着延长,而未复发的患者最大和总凝血酶浓度更高。相反,在停止抗凝治疗后一到两个月测量凝血酶的产生时,表明复发的患者具有更高的最大凝血酶浓度。结论我们的研究表明,VTE发生时的凝血酶生成曲线与急性发作后的临床病程相关。然而,有和没有复发的患者之间凝血酶产生的巨大重叠,使得在目前的知识水平上,对于每个患者来说,使用凝血酶产生概况来建议口服抗凝的时间长短值得怀疑。 ? 2012 Elsevier Ltd.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号